| 产品详情 |
| Edit |   |
|---|
| Product Name | MS 275 |
|---|
| Description | MW: 376.41. MS 275, also referred to as Entinostat, is a benzamide histone deacetylase inhibitor. It preferentially inhibits HDAC1 and HDAC3. It is currently undergoing several clinical trials for the treatment of Hodgkin's lymphoma, advanced breast cancer, and for metastatic lung cancer. |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate; N-(2-Aminophenyl)-4-[N-(pyridine-3ylmethoxycarbonyl)aminomethyl]benzamide |
|---|
| Gene, Accession, CAS # | CAS: 209783-80-2 |
|---|
| Catalog # | abx076834 |
|---|
| Price | |
|---|
| Order / More Info | MS 275 from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|